These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 15498131)

  • 1. [Inhibition effect of bone marrow mesenchymal stem cells on T-lymphocyte proliferation through up-regulation of CD8+CD28- T cells].
    Zhang W; Ge W; Li CH; You SG; Han Q; Deng WM; Zhao CH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Oct; 12(5):666-9. PubMed ID: 15498131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of bone marrow mesenchymal stem cells on T-cell subgroups].
    Zhang W; Yang M; Chen CF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):863-6. PubMed ID: 18718078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stromal cells augment CD4+ and CD8+ T-cell proliferation through a CCL2 pathway.
    Zhou Y; Day A; Haykal S; Keating A; Waddell TK
    Cytotherapy; 2013 Oct; 15(10):1195-207. PubMed ID: 23845188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased activation and expansion of a CD57+ subset within peripheral CD8+ T lymphocytes in Mycobacterium tuberculosis-infected patients.
    Fateminasab FD; Shahgasempour S; Mirsaeidi SM; Tabarsi P; Mansoori SD; Entezami Z
    Arch Iran Med; 2006 Jan; 9(1):53-7. PubMed ID: 16649379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human mesenchymal stromal cells enhance the immunomodulatory function of CD8(+)CD28(-) regulatory T cells.
    Liu Q; Zheng H; Chen X; Peng Y; Huang W; Li X; Li G; Xia W; Sun Q; Xiang AP
    Cell Mol Immunol; 2015 Nov; 12(6):708-18. PubMed ID: 25482073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of Human Bone Marrow Mesenchymal Stem Cells with Ectopic High OCT4 Expression on T Lymphocyte Function].
    Guo XP; Chen YF; Chen P; Pan J; Ying PT; Zhao N; Tang YM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1523-1530. PubMed ID: 37846711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.
    Jun HX; Jun CY; Yu ZX
    Haematologica; 2004 Dec; 89(12):1517-24. PubMed ID: 15590404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function.
    Ramasamy R; Tong CK; Seow HF; Vidyadaran S; Dazzi F
    Cell Immunol; 2008 Feb; 251(2):131-6. PubMed ID: 18502411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells control alloreactive CD8(+) CD28(-) T cells.
    Engela AU; Baan CC; Litjens NH; Franquesa M; Betjes MG; Weimar W; Hoogduijn MJ
    Clin Exp Immunol; 2013 Dec; 174(3):449-58. PubMed ID: 24028656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the T cell clones expanding within both CD8(+)CD28(+) and CD8(+)CD28(-) T cell subsets in recipients of allogeneic hematopoietic cell grafts and its implication in post-transplant skewing of T cell receptor repertoire.
    Horiuchi T; Hirokawa M; Kawabata Y; Kitabayashi A; Matsutani T; Yoshioka T; Tsuruta Y; Suzuki R; Miura AB
    Bone Marrow Transplant; 2001 Apr; 27(7):731-9. PubMed ID: 11360114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of bone marrow stromal cells in the generation of human CD8+ regulatory T cells.
    Poggi A; Zocchi MR
    Hum Immunol; 2008 Nov; 69(11):755-9. PubMed ID: 18817823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of CD28 costimulation in human CD8+ T cells.
    Lloyd TE; Yang L; Tang DN; Bennett T; Schober W; Lewis DE
    J Immunol; 1997 Feb; 158(4):1551-8. PubMed ID: 9029089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of CD8(+) and CD8(+)CD28(-) cell subsets in patients with hepatocellular carcinoma].
    Qiu YR; Yang CL; Chen LB; Wang Q
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Jan; 22(1):72-3. PubMed ID: 12390853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic value of changes of peripheral blood T cell subsets after thermoradiotherapy for nasopharyngeal carcinoma].
    Qiu YR; Zheng L; Yang CL; Wei D; Sun DH
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Jul; 24(7):818-20. PubMed ID: 15257913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD58/CD2 Is the Primary Costimulatory Pathway in Human CD28-CD8+ T Cells.
    Leitner J; Herndler-Brandstetter D; Zlabinger GJ; Grubeck-Loebenstein B; Steinberger P
    J Immunol; 2015 Jul; 195(2):477-87. PubMed ID: 26041540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effects of human bone marrow mesenchymal stem cells and cord blood mononuclear cells on mixed lymphocyte response and PHA induction transformation].
    Wei XF; Liu KY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):261-4. PubMed ID: 15228646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immune modulatory effects of mesenchymal stem cells on T lymphocytes in mixed lymphocyte culture].
    Xuan M; Qiu GQ; Xie XB
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):433-5. PubMed ID: 16806001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased lymphocyte beta-adrenergic receptor density in progressive multiple sclerosis is specific for the CD8+, CD28- suppressor cell.
    Karaszewski JW; Reder AT; Anlar B; Kim WC; Arnason BG
    Ann Neurol; 1991 Jul; 30(1):42-7. PubMed ID: 1656847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immune regulatory effect of human bone marrow mesenchymal stem cells on T lymphocyte].
    Lu XX; Liu T; Meng WT; Zhu HL; Xi YM; Liu YM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):651-5. PubMed ID: 16129053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.